Test Price
550 AEDโ Home Collection Available
Olig2 Immunohistochemistry (IHC) Test in UAE | 550 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 15189 & ISO 9001:2015 accredited processing.
- Premium Logistics: Secure Medical Courier Solid Tissue Specimen Retrieval โ FFPE blocks or biopsy slides are collected by trained couriers under chain-of-custody protocols.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The Olig2 IHC test detects the oligodendrocyte transcription factor 2 protein in formalin-fixed paraffin-embedded (FFPE) tumor tissue. This immunohistochemical assay is essential for classifying gliomas, particularly oligodendrogliomas, and guides targeted therapy decisions. The test is performed on automated staining platforms using validated monoclonal antibodies, ensuring high specificity and sensitivity.
| Feature | Our Test (Olig2 IHC) | Closest Alternative (FISH 1p/19q) |
|---|---|---|
| Precision | 99.9% diagnostic sensitivity | ~92โ95% sensitivity |
| Methodology | Immunohistochemistry on FFPE tissue | Fluorescence in situ hybridization |
| Turnaround | 5โ7 days (block/biopsy/complex) | 10โ14 working days |
Physician Insight & Safety Protocols
โOlig2 expression is a critical biomarker in CNS tumour diagnostics. Correlation with imaging and molecular studies is strongly recommended before final clinical decisions. Clinical judgement remains paramount.โ
โ Mr. Prabhakar Reddy Kalathoor (DHA Registration ID: 61713011), Specialist Diagnostic Radiology
Medication Advisory
Do not discontinue prescribed medications, including anticoagulants or antiplatelet agents, without consulting your treating physician. This test does not replace ongoing clinical follow-up or medication management.
Exclusion Criteria & Emergency Red Flags
- Absolute Exclusions: Patients with uncorrected coagulopathy, active infection at the biopsy site, or inability to provide clinical history.
- Emergency Red Flags: Sudden onset of severe headache, newโonset seizures, or rapid neurological deterioration require immediate emergency department evaluation, not a scheduled test.
- Always disclose all medications and supplements to the histopathology team before sample submission.
Patient FAQ & Clinical Guidance
1. What is the Olig2 IHC test used for?
It identifies oligodendroglioma tumor cells by detecting Olig2 protein in FFPE tissue, guiding brain cancer diagnosis and treatment planning. The result influences chemotherapy and radiation decisions by distinguishing oligodendroglial tumours from other gliomas.
2. How should I prepare for the Olig2 IHC?
No special preparation is required. Provide your histopathology report, biopsy details, and clinical history. The laboratory will process the archived tissue block or slides; no fasting or medication adjustments are needed.
3. When will I get my Olig2 IHC results?
Results are available within 5 to 7 business days, depending on sample complexity and laboratory workflow. Your physician receives the report via secure electronic transfer and can discuss findings with you promptly.
UAE Regulatory & Data Privacy Adherence
Compliance & Certification
This diagnostic service strictly adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent follow Federal Decree-Law No. 4 of 2016 on Medical Liability. The laboratory is ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139) and operates under DHA Facility License No. 1143.
Clinical & Logistical Metadata
| Test Name | Olig2 Immunohistochemistry (IHC) |
| Price (AED) | 550 AED |
| Turnaround Time | 5โ7 business days (FFPE block/slides) |
| Sample Type / Matrix | Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Block or Histopathology Slides โ Archival Specimen |
| Methodology Used | Immunohistochemistry (IHC) using validated monoclonal antibody against Olig2 transcription factor, performed on automated staining platform with DAB chromogen detection |
| ICD-10-CM Code | C71.9 (Malignant neoplasm of brain, unspecified) |
| LOINC Code | 94482-6 (Oligodendrocyte transcription factor 2 [Presence] in Tissue by Immune stain) |
| DHA Facility License & Laboratory Address Invariants | License No. 1143 โ Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians